Subcutaneous tissue is a promising alternative site for monitoring stress in vivo

SPIE Newsroom ◽  
2007 ◽  
Author(s):  
Francesco Baldini
Keyword(s):  
Subcutaneous Tissue ◽  
Promising Alternative ◽  
Alternative Site

scholarly journals Baicalin Represses Type Three Secretion System of Pseudomonas aeruginosa through PQS System

Molecules ◽  
2021 ◽  
Vol 26 (6) ◽  
pp. 1497
Author(s):  
Pansong Zhang ◽  
Qiao Guo ◽  
Zhihua Wei ◽  
Qin Yang ◽  
Zisheng Guo ◽  
...  
Keyword(s):  
Pseudomonas Aeruginosa ◽  
Virulence Factors ◽  
Mammalian Cells ◽  
Secretion System ◽  
Chinese Herbs ◽  
Infection Model ◽  
Lung Pathology ◽  
Promising Alternative ◽  
The Impact

Therapeutics that target the virulence of pathogens rather than their viability offer a promising alternative for treating infectious diseases and circumventing antibiotic resistance. In this study, we searched for anti-virulence compounds against Pseudomonas aeruginosa from Chinese herbs and investigated baicalin from Scutellariae radix as such an active anti-virulence compound. The effect of baicalin on a range of important virulence factors in P. aeruginosa was assessed using luxCDABE-based reporters and by phenotypical assays. The molecular mechanism of the virulence inhibition by baicalin was investigated using genetic approaches. The impact of baicalin on P. aeruginosa pathogenicity was evaluated by both in vitro assays and in vivo animal models. The results show that baicalin diminished a plenty of important virulence factors in P. aeruginosa, including the Type III secretion system (T3SS). Baicalin treatment reduced the cellular toxicity of P. aeruginosa on the mammalian cells and attenuated in vivo pathogenicity in a Drosophila melanogaster infection model. In a rat pulmonary infection model, baicalin significantly reduced the severity of lung pathology and accelerated lung bacterial clearance. The PqsR of the Pseudomonas quinolone signal (PQS) system was found to be required for baicalin’s impact on T3SS. These findings indicate that baicalin is a promising therapeutic candidate for treating P. aeruginosa infections.

scholarly journals Histological, Biomechanical, and Biological Properties of Genipin-Crosslinked Decellularized Peripheral Nerves

2021 ◽  
Vol 22 (2) ◽  
pp. 674
Author(s):  
Óscar Darío García-García ◽  
Marwa El Soury ◽  
David González-Quevedo ◽  
David Sánchez-Porras ◽  
Jesús Chato-Astrain ◽  
...  
Keyword(s):  
Ex Vivo ◽  
Nerve Repair ◽  
Wistar Rat ◽  
Biomechanical Properties ◽  
Biological Properties ◽  
Suitable Alternative ◽  
Promising Alternative ◽  
Histological Pattern ◽  
The Impact

Acellular nerve allografts (ANGs) represent a promising alternative in nerve repair. Our aim is to improve the structural and biomechanical properties of biocompatible Sondell (SD) and Roosens (RS) based ANGs using genipin (GP) as a crosslinker agent ex vivo. The impact of two concentrations of GP (0.10% and 0.25%) on Wistar rat sciatic nerve-derived ANGs was assessed at the histological, biomechanical, and biocompatibility levels. Histology confirmed the differences between SD and RS procedures, but not remarkable changes were induced by GP, which helped to preserve the nerve histological pattern. Tensile test revealed that GP enhanced the biomechanical properties of SD and RS ANGs, being the crosslinked RS ANGs more comparable to the native nerves used as control. The evaluation of the ANGs biocompatibility conducted with adipose-derived mesenchymal stem cells cultured within the ANGs confirmed a high degree of biocompatibility in all ANGs, especially in RS and RS-GP 0.10% ANGs. Finally, this study demonstrates that the use of GP could be an efficient alternative to improve the biomechanical properties of ANGs with a slight impact on the biocompatibility and histological pattern. For these reasons, we hypothesize that our novel crosslinked ANGs could be a suitable alternative for future in vivo preclinical studies.

scholarly journals In vivo optical endomicroscopy: two decades of translational research towards next generation diagnosis of eosinophilic esophagitis

2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Andreas Wartak ◽  
John G. Garber ◽  
Qian Yuan ◽  
Wayne G. Shreffler ◽  
Paul E. Hesterberg ◽  
...  
Keyword(s):  
Eosinophilic Esophagitis ◽  
Massachusetts General Hospital ◽  
Standard Of Care ◽  
Depth Information ◽  
Current Standard ◽  
Promising Alternative ◽  
White Light Endoscopy ◽  
Related Risk ◽  
Histopathologic Analysis

AbstractHistopathologic analysis of biopsy specimens obtained via white light endoscopy (WLE) is the gold standard for the diagnosis of several mucosal diseases in the upper gastrointestinal (GI) tract. However, this standard of care entails a series of critical shortcomings such as missing depth information, high costs, time inefficiency, low-resolution imaging in vivo, high sampling variability, missing intrinsic tissue-specific contrast, and anesthesia related risk. In the quest for a diagnostic technology to replace the current standard of care, in vivo optical endomicroscopy has emerged as a promising alternative. This paper tells the story of a cluster of optical microscopy-based modalities invented, further developed, or first-validated in the laboratory of Dr. Guillermo J. Tearney (Tearney Lab) at the Wellman Center for Photomedicine of Massachusetts General Hospital over the past two decades, that combined lead to a novel method for diagnosis of eosinophilic esophagitis (EoE). Rather than being a comprehensive literature review, this paper aims to describe the translational journey towards a disease specific diagnostic and research tool for this increasingly recognized yet poorly understood immune-mediated disorder of the esophagus.

Plant-assisted selection: a promising alternative for in vivo identification of wheat (Triticum turgidum L. subsp. Durum) growth promoting bacteria

2018 ◽  
Vol 435 (1-2) ◽  
pp. 367-384 ◽  
Author(s):  
Brenda Valenzuela-Aragon ◽  
Fannie Isela Parra-Cota ◽  
Gustavo Santoyo ◽  
Guillermo Luis Arellano-Wattenbarger ◽  
Sergio de los Santos-Villalobos
Keyword(s):  
Triticum Turgidum ◽  
Promising Alternative ◽  
Growth Promoting

scholarly journals Development and Evaluation of Clove and Cinnamon Supercritical Fluid Extracts-Loaded Emulgel for Antifungal Activity in Denture Stomatitis

Gels ◽  
2022 ◽  
Vol 8 (1) ◽  
pp. 33
Author(s):  
Meenakshi Srinivas Iyer ◽  
Anil Kumar Gujjari ◽  
Sathishbabu Paranthaman ◽  
Amr Selim Abu Lila ◽  
Khaled Almansour ◽  
...  
Keyword(s):  
Drug Release ◽  
Cure Rate ◽  
In Vitro Drug Release ◽  
Promising Alternative ◽  
Denture Stomatitis ◽  
Antifungal Effects ◽  
The Common ◽  
Central Composite

Denture stomatitis (DS), usually caused by Candida infection, is one of the common denture-related complications in patients wearing dentures. Clove and cinnamon oils have been acknowledged for their anti-inflammatory, antimicrobial activity, and antifungal effects in the oral cavity. The aim of this study, therefore, was to prepare clove/cinnamon oils-loaded emulgel and to assess its efficacy in treating Candida albicans-associated denture stomatitis. Central composite design was adopted to formulate and optimize clove/cinnamon extracts-loaded emulgel. The formulated preparations were assessed for their physical appearance, particle size, viscosity, spreadability, and in-vitro drug release. In addition, in-vivo therapeutic experiments were conducted on 42 patients with denture stomatitis. The prepared emulgel formulations showed good physical characteristics with efficient drug release within 3 h. In addition, in-vivo antifungal studies revealed that the optimized formula significantly (p < 0.001) reduced Candida colony counts from the denture surface, compared to commercially available gel (240.38 ± 27.20 vs. 398.19 ± 66.73 CFU/mL, respectively). Furthermore, the optimized formula and succeeded in alleviating denture stomatitis-related inflammation with a better clinical cure rate compared to commercially available gel Collectively, herbal extracts-loaded emulgel might be considered an evolution of polyherbal formulations and might represent a promising alternative to the existing allopathic drugs for the treatment of denture stomatitis, with better taste acceptability and no side effects.

scholarly journals Fabrication and evaluation of an optimized xenogenic decellularized costal cartilage graft: preclinical studies of a novel biocompatible prosthesis for rhinoplasty

2021 ◽  
Author(s):  
Shuang Lin ◽  
Yuanjia He ◽  
Meihan Tao ◽  
Aijun Wang ◽  
Qiang Ao
Keyword(s):  
Costal Cartilage ◽  
Donor Site ◽  
Rabbit Model ◽  
Operation Time ◽  
Promising Alternative ◽  
Ionic Detergent ◽  
Cellular Components ◽  
First Time

Abstract On account of the poor biocompatibility of synthetic prosthesis, millions of rhinoplasty recipients have been forced to choose autologous costal cartilage as grafts, which suffer from limited availability, morbidity at donor site and prolonged operation time. Here, as a promising alternative to autologous costal cartilage, we developed a novel xenogeneic costal cartilage and explored its feasibility as a rhinoplasty graft for the first time. Adopting an improved decellularization protocol, in which the ionic detergent was substituted by trypsin, the resulting decellularized graft was confirmed to preserve more structural components and better mechanics, and eliminate cellular components effectively. The in vitro and in vivo compatibility experiments demonstrated that the decellularized graft showed excellent biocompatibility and biosecurity. Additionally, the functionality assessment of rhinoplasty was performed in a rabbit model, and the condition of grafts after implantation was comprehensively evaluated. The optimized graft exhibited better capacity to reduce the degradation rate and maintain the morphology, in comparison to the decellularized costal cartilage prepared by conventional protocol. These findings indicate that this optimized graft derived from decellularized xenogeneic costal cartilage provides a new prospective for future investigations of rhinoplasty prosthesis and has great potential for clinical application.

scholarly journals Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19

Pharmaceutics ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1260
Author(s):  
Waiting Tai ◽  
Michael Yee Tak Chow ◽  
Rachel Yoon Kyung Chang ◽  
Patricia Tang ◽  
Igor Gonda ◽  
...  
Keyword(s):  
Drug Concentration ◽  
Systemic Exposure ◽  
Oral Route ◽  
Liquid Volume ◽  
Global Public Health ◽  
Promising Alternative ◽  
High Drug Concentration ◽  
Preclinical And Clinical Studies

The coronavirus disease 2019 (COVID-19) is an unprecedented pandemic that has severely impacted global public health and the economy. Hydroxychloroquine administered orally to COVID-19 patients was ineffective, but its antiviral and anti-inflammatory actions were observed in vitro. The lack of efficacy in vivo could be due to the inefficiency of the oral route in attaining high drug concentration in the lungs. Delivering hydroxychloroquine by inhalation may be a promising alternative for direct targeting with minimal systemic exposure. This paper reports on the characterisation of isotonic, pH-neutral hydroxychloroquine sulphate (HCQS) solutions for nebulisation for COVID-19. They can be prepared, sterilised, and nebulised for testing as an investigational new drug for treating this infection. The 20, 50, and 100 mg/mL HCQS solutions were stable for at least 15 days without refrigeration when stored in darkness. They were atomised from Aerogen Solo Ultra vibrating mesh nebulisers (1 mL of each of the three concentrations and, in addition, 1.5 mL of 100 mg/mL) to form droplets having a median volumetric diameter of 4.3–5.2 µm, with about 50–60% of the aerosol by volume < 5 µm. The aerosol droplet size decreased (from 4.95 to 4.34 µm) with increasing drug concentration (from 20 to 100 mg/mL). As the drug concentration and liquid volume increased, the nebulisation duration increased from 3 to 11 min. The emitted doses ranged from 9.1 to 75.9 mg, depending on the concentration and volume nebulised. The HCQS solutions appear suitable for preclinical and clinical studies for potential COVID-19 treatment.

scholarly journals Functionalized Nanoparticles Activated by Photodynamic Therapy as an Antimicrobial Strategy in Endodontics: A Scoping Review

Antibiotics ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 1064
Author(s):  
Pablo Betancourt ◽  
Nadia Brocal ◽  
Eulàlia Sans-Serramitjana ◽  
Carlos Zaror
Keyword(s):  
Photodynamic Therapy ◽  
Scoping Review ◽  
Selection Process ◽  
Data Extraction ◽  
Cochrane Library ◽  
Qualitative Synthesis ◽  
Promising Alternative ◽  
Root Canals ◽  
Low Cytotoxicity

The eradication of endodontic pathogens continues to be the focus of the search for new root canal system (RCS) disinfection strategies. This scoping review provides a comprehensive synthesis of antimicrobial photodynamic therapy (aPDT) using nanoparticles (NPs) as an alternative to optimize RCS disinfection. A systematic search up to March 2021 was carried out using the MEDLINE, EMBASE, Scopus, Lilacs, Central Cochrane Library, and BBO databases. We included studies focused on evaluating the activation of NPs by aPDT in inoculated root canals of human or animal teeth or bacterial cultures in the laboratory. The selection process and data extraction were carried out by two researchers independently. A qualitative synthesis of the results was performed. A total of seventeen studies were included, of which twelve showed a substantial antibacterial efficacy, two assessed the substantivity of the disinfection effect, and three showed low cytotoxicity. No adverse effects were reported. The use of functionalized NPs with photosensitizer molecules in aPDT has been shown to be effective in reducing the bacteria count, making it a promising alternative in endodontic disinfection. Further studies are needed to assess the development of this therapy in in vivo conditions, with detailed information about the laser parameters used to allow the development of safe and standardized protocols.

Identification of Chemotherapeutic Dihydromyricetin With Enhanced Anti-tumor Activity and Biosafety for Muscle Invasive Bladder Cancer

2021 ◽  
Author(s):  
Zijian Wang ◽  
Zicheng Guo ◽  
Wenjie You ◽  
Wang Wang ◽  
Fenfang Zhou ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Macrophage Polarization ◽  
Xenograft Model ◽  
Postoperative Chemotherapy ◽  
In Vitro Tests ◽  
Promising Alternative ◽  
Mesenchymal Transition ◽  
Muscle Invasive ◽  
Anti Tumor Activity

Abstract Background: Muscle invasive bladder cancer (MIBC) is one of the most common malignant diseases in elderly men, such as veterans. Postoperative chemotherapy plays a vital role in preventing recurrence and metastasis of MIBC. However, fewer of chemotherapeutic drugs with remarkable anti-tumor activity and biosafety are available for clinical treatment.Methods: In this work, a novel plant-derived drug, named as dihydromyricetin (DHM), was selected for postoperative chemotherapy of MIBC. The anti-tumor activity was evaluated using a series of in vitro tests, such as MTT assay, flow cytometry and western blot. Furthermore, a xenograft model of BALB/C57 nude mice was established to verify the good anti-tumor activity and biosafety of DHM in vivo. Results: DHM could effectively inhibit the proliferation, survival and migration of MIBC cell, and promote apoptosis (P<0.05). Cytotoxic macrophage polarization from M0 to M1 was promoted by DHM treatment, and the hub genes in cell cycle and apoptosis signaling pathways were differential expressed. We also found that DHM could reverse the epithelial-mesenchymal transition (EMT) of MIBC cell. The in vivo results revealed that intravenous injection of DHM with a dose of 20 mg/kg for 7 times could significantly suppress the in vivo tumorigenesis of MIBC (P<0.05), while triggered no obvious drug side effects. Conclusion: This work identified a novel chemotherapeutic DHM with remarkable anti-tumor activity and biosafety, which could serve as a promising alternative for postoperative chemotherapy of MIBC.

scholarly journals Synthetic Peptides as a Promising Alternative to Control Viral Infections in Atlantic Salmon

Pathogens ◽  
2020 ◽  
Vol 9 (8) ◽  
pp. 600 ◽  
Author(s):  
Constanza Cárdenas ◽  
Fanny Guzmán ◽  
Marisela Carmona ◽  
Cristian Muñoz ◽  
Luis Nilo ◽  
...  
Keyword(s):  
Viral Load ◽  
Viral Infections ◽  
Antiviral Agents ◽  
In Silico Analysis ◽  
Infectious Pancreatic Necrosis Virus ◽  
Fish Cell ◽  
Promising Alternative ◽  
Anemia Virus

Viral infections in salmonids represent an ongoing challenge for the aquaculture industry. Two RNA viruses, the infectious pancreatic necrosis virus (IPNV) and the infectious salmon anemia virus (ISAV), have become a latent risk without healing therapies available for either. In this context, antiviral peptides emerge as effective and relatively safe therapeutic molecules. Based on in silico analysis of VP2 protein from IPNV and the RNA-dependent RNA polymerase from ISAV, a set of peptides was designed and were chemically synthesized to block selected key events in their corresponding infectivity processes. The peptides were tested in fish cell lines in vitro, and four were selected for decreasing the viral load: peptide GIM182 for IPNV, and peptides GIM535, GIM538 and GIM539 for ISAV. In vivo tests with the IPNV GIM 182 peptide were carried out using Salmo salar fish, showing a significant decrease of viral load, and proving the safety of the peptide for fish. The results indicate that the use of peptides as antiviral agents in disease control might be a viable alternative to explore in aquaculture.

Sign in / Sign up

Export Citation Format

Share Document